| Title |
Metformin: a review of its potential indications
|
|---|---|
| Published in |
Drug Design, Development and Therapy, August 2017
|
| DOI | 10.2147/dddt.s141675 |
| Pubmed ID | |
| Authors |
Yi-Wei Wang, Si-Jia He, Xiao Feng, Jin Cheng, Yun-Tao Luo, Ling Tian, Qian Huang |
| Abstract |
Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years, in addition to glucose lowering, several studies have presented evidence suggesting some potential role for metformin, such as antitumor effect, antiaging effect, cardiovascular protective effect, neuroprotective effect or an optional treatment for polycystic ovary syndrome. This paper will critically review the role of metformin to provide reference for doctors and researchers. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 25% |
| Brazil | 1 | 13% |
| France | 1 | 13% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 63% |
| Practitioners (doctors, other healthcare professionals) | 3 | 38% |
Mendeley readers
The data shown below were compiled from readership statistics for 485 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 485 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 89 | 18% |
| Student > Master | 59 | 12% |
| Student > Ph. D. Student | 39 | 8% |
| Researcher | 35 | 7% |
| Student > Doctoral Student | 29 | 6% |
| Other | 66 | 14% |
| Unknown | 168 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 92 | 19% |
| Pharmacology, Toxicology and Pharmaceutical Science | 55 | 11% |
| Biochemistry, Genetics and Molecular Biology | 54 | 11% |
| Agricultural and Biological Sciences | 18 | 4% |
| Nursing and Health Professions | 16 | 3% |
| Other | 65 | 13% |
| Unknown | 185 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 208. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2023.
All research outputs
#192,236
of 25,800,372 outputs
Outputs from Drug Design, Development and Therapy
#18
of 2,282 outputs
Outputs of similar age
#4,001
of 328,677 outputs
Outputs of similar age from Drug Design, Development and Therapy
#1
of 47 outputs
Altmetric has tracked 25,800,372 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,282 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,677 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.